Cargando…
Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein
The amyloid precursor protein (APP) harbors physiological roles at synapses and is central to Alzheimer’s disease (AD) pathogenesis. Evidence suggests that APP intracellular domain (AICD) could regulate synapse function, but the underlying molecular mechanisms remain unknown. We addressed AICD actio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544428/ https://www.ncbi.nlm.nih.gov/pubmed/28682239 http://dx.doi.org/10.7554/eLife.25659 |
_version_ | 1783255255607148544 |
---|---|
author | Pousinha, Paula A Mouska, Xavier Raymond, Elisabeth F Gwizdek, Carole Dhib, Gihen Poupon, Gwenola Zaragosi, Laure-Emmanuelle Giudici, Camilla Bethus, Ingrid Pacary, Emilie Willem, Michael Marie, Hélène |
author_facet | Pousinha, Paula A Mouska, Xavier Raymond, Elisabeth F Gwizdek, Carole Dhib, Gihen Poupon, Gwenola Zaragosi, Laure-Emmanuelle Giudici, Camilla Bethus, Ingrid Pacary, Emilie Willem, Michael Marie, Hélène |
author_sort | Pousinha, Paula A |
collection | PubMed |
description | The amyloid precursor protein (APP) harbors physiological roles at synapses and is central to Alzheimer’s disease (AD) pathogenesis. Evidence suggests that APP intracellular domain (AICD) could regulate synapse function, but the underlying molecular mechanisms remain unknown. We addressed AICD actions at synapses, per se, combining in vivo AICD expression, ex vivo AICD delivery or APP knock-down by in utero electroporation of shRNAs with whole-cell electrophysiology. We report a critical physiological role of AICD in controlling GluN2B-containing NMDA receptors (NMDARs) at immature excitatory synapses, via a transcription-dependent mechanism. We further show that AICD increase in mature neurons, as reported in AD, alters synaptic NMDAR composition to an immature-like GluN2B-rich profile. This disrupts synaptic signal integration, via over-activation of SK channels, and synapse plasticity, phenotypes rescued by GluN2B antagonism. We provide a new physiological role for AICD, which becomes pathological upon AICD increase in mature neurons. Thus, AICD could contribute to AD synaptic failure. DOI: http://dx.doi.org/10.7554/eLife.25659.001 |
format | Online Article Text |
id | pubmed-5544428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55444282017-08-07 Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein Pousinha, Paula A Mouska, Xavier Raymond, Elisabeth F Gwizdek, Carole Dhib, Gihen Poupon, Gwenola Zaragosi, Laure-Emmanuelle Giudici, Camilla Bethus, Ingrid Pacary, Emilie Willem, Michael Marie, Hélène eLife Neuroscience The amyloid precursor protein (APP) harbors physiological roles at synapses and is central to Alzheimer’s disease (AD) pathogenesis. Evidence suggests that APP intracellular domain (AICD) could regulate synapse function, but the underlying molecular mechanisms remain unknown. We addressed AICD actions at synapses, per se, combining in vivo AICD expression, ex vivo AICD delivery or APP knock-down by in utero electroporation of shRNAs with whole-cell electrophysiology. We report a critical physiological role of AICD in controlling GluN2B-containing NMDA receptors (NMDARs) at immature excitatory synapses, via a transcription-dependent mechanism. We further show that AICD increase in mature neurons, as reported in AD, alters synaptic NMDAR composition to an immature-like GluN2B-rich profile. This disrupts synaptic signal integration, via over-activation of SK channels, and synapse plasticity, phenotypes rescued by GluN2B antagonism. We provide a new physiological role for AICD, which becomes pathological upon AICD increase in mature neurons. Thus, AICD could contribute to AD synaptic failure. DOI: http://dx.doi.org/10.7554/eLife.25659.001 eLife Sciences Publications, Ltd 2017-07-06 /pmc/articles/PMC5544428/ /pubmed/28682239 http://dx.doi.org/10.7554/eLife.25659 Text en © 2017, Pousinha et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Neuroscience Pousinha, Paula A Mouska, Xavier Raymond, Elisabeth F Gwizdek, Carole Dhib, Gihen Poupon, Gwenola Zaragosi, Laure-Emmanuelle Giudici, Camilla Bethus, Ingrid Pacary, Emilie Willem, Michael Marie, Hélène Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein |
title | Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein |
title_full | Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein |
title_fullStr | Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein |
title_full_unstemmed | Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein |
title_short | Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein |
title_sort | physiological and pathophysiological control of synaptic glun2b-nmda receptors by the c-terminal domain of amyloid precursor protein |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544428/ https://www.ncbi.nlm.nih.gov/pubmed/28682239 http://dx.doi.org/10.7554/eLife.25659 |
work_keys_str_mv | AT pousinhapaulaa physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT mouskaxavier physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT raymondelisabethf physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT gwizdekcarole physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT dhibgihen physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT poupongwenola physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT zaragosilaureemmanuelle physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT giudicicamilla physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT bethusingrid physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT pacaryemilie physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT willemmichael physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein AT mariehelene physiologicalandpathophysiologicalcontrolofsynapticglun2bnmdareceptorsbythecterminaldomainofamyloidprecursorprotein |